Minnow Street Minnow Street
Buy Day today: Neutral (53) Mixed market breadth · no major macro event

Danaher Corporation (DHR)

Healthcare Diagnostics & Research
195.00 $
-0.6% vs. previous close
Closing price · As of: 31. Jul 2026

Danaher Corporation (DHR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 92,367 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow
Annual Quarterly

All figures in millions of USD.

Balance Sheet DHR
Tick rows to compare them in a chart (up to 4) Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
87,734 84,488 83,402 78,555 80,615 77,542 79,116 81,620 79,897 83,464 83,544 92,367
21,205 13,937 14,372 9,609 10,060 9,497 9,525 10,999 9,606 12,756 13,935 13,381
12,277 5,864 7,031 2,374 2,627 2,078 1,993 2,957 1,528 4,615 5,701 4,348
12,277 5,864 7,031 2,374 2,627 2,078 1,993 2,957 1,528 4,615 5,701 4,348
4,201 4,637 3,379 3,298 3,507 4,390 4,314 4,516 3,755 3,913 3,819 3,965
3,024 2,594 2,645 2,671 2,678 2,330 2,532 2,689 2,674 2,489 2,608 3,260
5,302 – – – 6,043 6,074 6,210 6,409 6,576 5,531 – –
39,155 41,608 40,846 40,805 42,173 40,497 41,657 42,991 42,948 43,151 42,765 47,414
18,786 20,746 19,888 19,545 19,854 18,568 18,885 18,629 18,097 17,817 17,166 21,358
35,319 30,998 29,955 28,653 29,310 27,992 28,259 29,278 28,826 30,930 30,595 39,786
9,367 8,274 7,778 6,701 7,339 6,798 6,645 6,792 6,324 6,807 7,460 8,105
3,647 1,875 2,846 1,901 2,500 678 1,601 1,702 23 2.0 923 1,411
1,894 1,766 1,679 1,645 1,596 1,753 1,722 1,725 1,698 1,844 1,790 1,822
19,513 16,707 16,417 16,309 16,324 15,500 15,976 16,853 16,833 18,416 17,561 25,147
52,407 53,486 53,442 49,897 51,299 49,543 50,849 52,334 51,071 52,534 52,949 52,581
42,272 41,074 41,962 42,673 43,296 44,188 44,913 45,239 45,920 46,891 47,637 48,226
746 746 749 742 729 737 721 719 714 711 711 708

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?